Cargando…

Subcentimeter Nodules with Diagnostic Hallmarks of Hepatocellular Carcinoma: Comparison of Pathological Features and Survival Outcomes with Nodules Measuring 1–2 cm

OBJECTIVE: To compare the pathologic diagnosis and survival of patients with subcentimeter and 1–2 cm nodules that present with diagnostic hallmarks of hepatocellular carcinoma (HCC). METHODS: Diagnostic hallmarks of HCC were defined as hyperintensity on T2 weighted imaging, restricted diffusion, ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Peng, Ni, Xiaoyan, Zhou, Changwu, Shi, Zhang, Wu, Fei, Xiao, Yuyao, Yang, Chun, Zeng, Mengsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922505/
https://www.ncbi.nlm.nih.gov/pubmed/36789251
http://dx.doi.org/10.2147/JHC.S401027
_version_ 1784887549600202752
author Huang, Peng
Ni, Xiaoyan
Zhou, Changwu
Shi, Zhang
Wu, Fei
Xiao, Yuyao
Yang, Chun
Zeng, Mengsu
author_facet Huang, Peng
Ni, Xiaoyan
Zhou, Changwu
Shi, Zhang
Wu, Fei
Xiao, Yuyao
Yang, Chun
Zeng, Mengsu
author_sort Huang, Peng
collection PubMed
description OBJECTIVE: To compare the pathologic diagnosis and survival of patients with subcentimeter and 1–2 cm nodules that present with diagnostic hallmarks of hepatocellular carcinoma (HCC). METHODS: Diagnostic hallmarks of HCC were defined as hyperintensity on T2 weighted imaging, restricted diffusion, arterial phase hyperenhancement, washout on portal venous phase, and hypointensity on hepatobiliary phase. We retrospectively included 139 patients undergoing curative resection with single nodules ≤2 cm that present imaging features described above on gadoxetic acid-enhanced MRI. The final diagnosis was confirmed by histopathological assessment. Recurrence-free survival (RFS) was compared using Kaplan–Meier analysis with the Log-rank test. Factors associated with overall and early recurrence were identified using Cox regression analysis. RESULTS: Among 139 nodules (49 nodules <1 cm), there was no significant difference in the percentage of HCC between subcentimeter and 1–2 cm nodules (94.0% vs 94.4%, P > 0.999). Microvascular invasion (MVI) was less common in subcentimeter HCC (4.3% vs 17.6%, P = 0.032). There were 27 recurrences during a median follow-up time of 46.7 months. Patients with subcentimeter HCC achieved less recurrence, with a 5-year RFS rate of 87.3%. The MVI-positive patients had more early and overall recurrence. A tumor size <1 cm was associated with lower overall recurrence (HR, 0.336; P = 0.047). No factors were independently associated with early recurrence. CONCLUSION: Subcentimeter nodules with diagnostic hallmarks of HCC are highly associated with HCC diagnosis and achieve less tumor recurrence after resection. Early diagnosis and treatment of subcentimeter HCC may be more appropriate.
format Online
Article
Text
id pubmed-9922505
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-99225052023-02-13 Subcentimeter Nodules with Diagnostic Hallmarks of Hepatocellular Carcinoma: Comparison of Pathological Features and Survival Outcomes with Nodules Measuring 1–2 cm Huang, Peng Ni, Xiaoyan Zhou, Changwu Shi, Zhang Wu, Fei Xiao, Yuyao Yang, Chun Zeng, Mengsu J Hepatocell Carcinoma Original Research OBJECTIVE: To compare the pathologic diagnosis and survival of patients with subcentimeter and 1–2 cm nodules that present with diagnostic hallmarks of hepatocellular carcinoma (HCC). METHODS: Diagnostic hallmarks of HCC were defined as hyperintensity on T2 weighted imaging, restricted diffusion, arterial phase hyperenhancement, washout on portal venous phase, and hypointensity on hepatobiliary phase. We retrospectively included 139 patients undergoing curative resection with single nodules ≤2 cm that present imaging features described above on gadoxetic acid-enhanced MRI. The final diagnosis was confirmed by histopathological assessment. Recurrence-free survival (RFS) was compared using Kaplan–Meier analysis with the Log-rank test. Factors associated with overall and early recurrence were identified using Cox regression analysis. RESULTS: Among 139 nodules (49 nodules <1 cm), there was no significant difference in the percentage of HCC between subcentimeter and 1–2 cm nodules (94.0% vs 94.4%, P > 0.999). Microvascular invasion (MVI) was less common in subcentimeter HCC (4.3% vs 17.6%, P = 0.032). There were 27 recurrences during a median follow-up time of 46.7 months. Patients with subcentimeter HCC achieved less recurrence, with a 5-year RFS rate of 87.3%. The MVI-positive patients had more early and overall recurrence. A tumor size <1 cm was associated with lower overall recurrence (HR, 0.336; P = 0.047). No factors were independently associated with early recurrence. CONCLUSION: Subcentimeter nodules with diagnostic hallmarks of HCC are highly associated with HCC diagnosis and achieve less tumor recurrence after resection. Early diagnosis and treatment of subcentimeter HCC may be more appropriate. Dove 2023-02-08 /pmc/articles/PMC9922505/ /pubmed/36789251 http://dx.doi.org/10.2147/JHC.S401027 Text en © 2023 Huang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Huang, Peng
Ni, Xiaoyan
Zhou, Changwu
Shi, Zhang
Wu, Fei
Xiao, Yuyao
Yang, Chun
Zeng, Mengsu
Subcentimeter Nodules with Diagnostic Hallmarks of Hepatocellular Carcinoma: Comparison of Pathological Features and Survival Outcomes with Nodules Measuring 1–2 cm
title Subcentimeter Nodules with Diagnostic Hallmarks of Hepatocellular Carcinoma: Comparison of Pathological Features and Survival Outcomes with Nodules Measuring 1–2 cm
title_full Subcentimeter Nodules with Diagnostic Hallmarks of Hepatocellular Carcinoma: Comparison of Pathological Features and Survival Outcomes with Nodules Measuring 1–2 cm
title_fullStr Subcentimeter Nodules with Diagnostic Hallmarks of Hepatocellular Carcinoma: Comparison of Pathological Features and Survival Outcomes with Nodules Measuring 1–2 cm
title_full_unstemmed Subcentimeter Nodules with Diagnostic Hallmarks of Hepatocellular Carcinoma: Comparison of Pathological Features and Survival Outcomes with Nodules Measuring 1–2 cm
title_short Subcentimeter Nodules with Diagnostic Hallmarks of Hepatocellular Carcinoma: Comparison of Pathological Features and Survival Outcomes with Nodules Measuring 1–2 cm
title_sort subcentimeter nodules with diagnostic hallmarks of hepatocellular carcinoma: comparison of pathological features and survival outcomes with nodules measuring 1–2 cm
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922505/
https://www.ncbi.nlm.nih.gov/pubmed/36789251
http://dx.doi.org/10.2147/JHC.S401027
work_keys_str_mv AT huangpeng subcentimeternoduleswithdiagnostichallmarksofhepatocellularcarcinomacomparisonofpathologicalfeaturesandsurvivaloutcomeswithnodulesmeasuring12cm
AT nixiaoyan subcentimeternoduleswithdiagnostichallmarksofhepatocellularcarcinomacomparisonofpathologicalfeaturesandsurvivaloutcomeswithnodulesmeasuring12cm
AT zhouchangwu subcentimeternoduleswithdiagnostichallmarksofhepatocellularcarcinomacomparisonofpathologicalfeaturesandsurvivaloutcomeswithnodulesmeasuring12cm
AT shizhang subcentimeternoduleswithdiagnostichallmarksofhepatocellularcarcinomacomparisonofpathologicalfeaturesandsurvivaloutcomeswithnodulesmeasuring12cm
AT wufei subcentimeternoduleswithdiagnostichallmarksofhepatocellularcarcinomacomparisonofpathologicalfeaturesandsurvivaloutcomeswithnodulesmeasuring12cm
AT xiaoyuyao subcentimeternoduleswithdiagnostichallmarksofhepatocellularcarcinomacomparisonofpathologicalfeaturesandsurvivaloutcomeswithnodulesmeasuring12cm
AT yangchun subcentimeternoduleswithdiagnostichallmarksofhepatocellularcarcinomacomparisonofpathologicalfeaturesandsurvivaloutcomeswithnodulesmeasuring12cm
AT zengmengsu subcentimeternoduleswithdiagnostichallmarksofhepatocellularcarcinomacomparisonofpathologicalfeaturesandsurvivaloutcomeswithnodulesmeasuring12cm